Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5) Peptid
Kurzübersicht für Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5) Peptid (ABIN937353)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- DGSQVDIILE DQDVDKRDFF DNGEWEIVSA TGSKGNRTDS CCWYPYVTYS
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CHRNA5 antibody,
Alternative Names: CHRNA5 control peptide, CHRNA5 antibody Blocking Peptide, Anti-CHRNA5 Blocking Peptide, Cholinergic Receptor Nicotinic Alpha 5 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- CHRNA5 (Cholinergic Receptor, Nicotinic, alpha 5 (Neuronal) (CHRNA5))
-
Hintergrund
- Nicotinic acetylcholine receptors (nAChRs), such as CHRNA5, are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are thought to be (hetero)pentamers composed of homologous subunits.
-
Molekulargewicht
- 53 kDa
Target
-